Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 2/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | PLAU | P00749 | 2/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | F10 | P00742 | 1/20 | 0.44 |
| ▸ | PLG | P00747 | 1/20 | 0.44 |
| ▸ | PLAT | P00750 | 1/20 | 0.44 |
| ▸ | KLK1 | P06870 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1758307 | 0.82 | KMT2A (0.78) | ALDH1A1KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL29743740 | 0.80 | ALDH1A1 (0.69) | ALDH1A1KDM4EHPGDHSD17B10KMT2A | |
| Hydroxytoluic Acid SCHEMBL29499765 | 0.80 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL9539588 | 0.80 | ESR1 (0.49) | ALDH1A1KDM4EHPGDHSD17B10KMT2A | |
| Hydroxytoluic Acid SCHEMBL8352264 | 0.80 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10KMT2A | |
| Hydroxytoluic Acid SCHEMBL28037743 | 0.80 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL2051695 | 0.80 | ALDH1A1 (0.69) | ALDH1A1KDM4EHPGDHSD17B10KMT2A | |
| Hydroxytoluic Acid SCHEMBL25756 | 0.80 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL20853594 | 0.80 | ALDH1A1 (0.69) | ALDH1A1KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL1029640 | 0.79 | HPGD (0.50) | ALDH1A1KDM4EHPGDHSD17B10KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3338813-B2 | MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER | BSN MEDICAL GMBH (DE) | 2026-04-15 | — | — | EP | claimed |
| EP-3558399-B2 | MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER | BSN MEDICAL GMBH (DE) | 2026-01-14 | — | — | EP | claimed |
| EP-4095097-B1 | METAL-ADSORBING COMPOSITE MATERIAL BASED ON MAGNETIC GRAPHENE OXIDE AND METHOD FOR OBTAINING SAME | UNIV MALAGA (ES) | 2025-10-01 | — | — | EP | claimed |
| EP-3842076-B1 | MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER | BSN MEDICAL GMBH (DE) | 2023-02-15 | — | — | EP | claimed |
| CN-110087695-B | Multilayer wound care product with perforated release layer | BSN医疗有限公司 | 2022-02-25 | — | — | CN | claimed |
| EP-3842076-A1 | MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER | BSN medical GmbH (DE) | 2021-06-30 | — | — | EP | claimed |
| EP-3558399-B1 | MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER | BSN MEDICAL GMBH (DE) | 2021-01-20 | — | — | EP | claimed |
| EP-3338813-B1 | MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER | BSN MEDICAL GMBH (DE) | 2020-01-29 | — | — | EP | claimed |
| US-20190328926-A1 | MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER | BSN MEDICAL GMBH (DE) | 2019-10-31 | — | — | US | claimed |
| EP-3558399-A1 | MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER | BSN medical GmbH (DE) | 2019-10-30 | — | — | EP | claimed |
| US-6436996-B1 | Modulation of nitric oxide production | DUKE UNIVERSITY | 2002-08-20 | — | — | US | claimed |
| EP-1187605-A1 | NON-MALIGNANT DISEASE TREATMENT WITH RAS ANTAGONISTS | Thyreos Corporation (US) | 2002-03-20 | — | — | EP | claimed |
| WO-2001070199-A1 | MATRICES CONTAINING NITRIC OXIDE DONORS AND REDUCING AGENTS AND THEIR USE | NOVOVASCULAR, INC. (US) | 2001-09-27 | — | — | WO | claimed |
| EP-0784429-A4 | METHOD AND FORMULATION OF STIMULATING NITRIC OXIDE SYNTHESIS | KAESEMEYER W H (US) | 2001-02-07 | — | — | EP | claimed |
| WO-2000078303-A1 | NON-MALIGNANT DISEASE TREATMENT WITH RAS ANTAGONISTS | THYREOS CORPORATION (US) | 2000-12-28 | — | — | WO | claimed |
| EP-1019079-A1 | MODULATION OF NITRIC OXIDE PRODUCTION | DUKE UNIVERSITY (US) | 2000-07-19 | — | — | EP | claimed |
| WO-1999016464-A1 | MODULATION OF NITRIC OXIDE PRODUCTION | DUKE UNIVERSITY (US) | 1999-04-08 | — | — | WO | claimed |
| EP-0784429-A1 | METHOD AND FORMULATION OF STIMULATING NITRIC OXIDE SYNTHESIS | Kaesemeyer, W., H. (US) | 1997-07-23 | — | — | EP | claimed |
| US-5543430-A | ADMINISTERING MIXTURE OF ARGININE AND VENOUS DILATOR UNTIL DESIRABLE STATE OF VASORELAXATION IS OBTAINED | PALMETTO PHARMACEUTICALS, LLC | 1996-08-06 | — | — | US | claimed |
| WO-1996010910-A9 | METHOD AND FORMULATION OF STIMULATING NITRIC OXIDE SYNTHESIS | — | 1996-05-23 | — | — | WO | claimed |